Annual review 2023
Between stubborn threats to population health and the rapid pace of research and innovation, PHG’s mission, ‘to make science work for health’ is, if anything, more important now than it has been at any point in our history.
It has been a phenomenally busy period, even by PHG’s standards, which has resulted in some important and influential analyses of emerging health technologies, from polygenic scores to synthetic data, and the complex policy challenges they raise.
In between all the business as usual we were thrilled to welcome Dr Peter Mills as the new Director of the PHG Foundation. We also celebrated an important landmark – our 25th anniversary. We marked the occasion with a gala dinner and the policy summit where we took stock of the progress of genomics and related technologies, and the rules, policies, practices and institutions around them. We are looking ahead to the future with refreshed determination to make science work for health, for all.
Public affairs
Shaping health policy means sharing our intelligence and insights with decision-makers, planners and influencers in Westminster, Whitehall and across the wider stakeholder community.
We provide constructive, non-partisan and evidence-based advice for policy development, through formal meetings and working groups, bespoke briefings and reports, and our own publications. We also contribute to public discussion of the wider policy issues in science, technology, innovation and health.
Case studies
We’re proud of what we have achieved, from health futures planning for emerging science-based innovations to setting out the practical steps necessary for the integration of genomics in mainstream medical care, the introduction of non-invasive testing in pregnancy and cancer, or driving important amendments to critical UK and European legislation that affect the use of science in healthcare.